Resultados da pesquisa - Portal para modelos de dados médicos (portal MDM)

Lung Cancer NCT00632853 Treatment - CALGB: 30610 Treatment and Response Form - 2688627v1.0 - CALGB: 30610 Treatment and Response Form

- 08/01/2015 - 1 Formulário, 5 Grupos de itens, 35 Elementos de dados, 1 Idioma

Grupos de itens: Header, Survival Date, Treatment Data, Response Data, Footer

CALGB: 30610 Treatment and Response Form Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3C3834F7-372A-2795-E044-0003BA3F9857

Lung Cancer NCT00049543 Response - Form 9 - Relapse/ Progressive Disease Report - 2034459v3.0 - Form 9 - Relapse/ Progressive Disease Report

- 09/01/2015 - 1 Formulário, 8 Grupos de itens, 50 Elementos de dados, 2 Idiomas

Grupos de itens: 1. PATIENT INFORMATION, Radiology, 3. DISEASE STATUS, NCIC CTG use only, 4. RECURRENCE TABLE, 5. TREATMENT PLAN , 6. COMMENTS, 8. INVESTIGATOR SIGNATURE

Form 9 - Relapse/ Progressive Disease Report Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A06B0201-DAB9-5179-E034-080020C9C0E0

Response - PHASE II LUNG CANCER ¿ BASELINE SOLID TUMOR EVALUATION FORM - 2400961v1.0 - PHASE II LUNG CANCER ¿ BASELINE SOLID TUMOR EVALUATION FORM

- 09/01/2015 - 1 Formulário, 5 Grupos de itens, 28 Elementos de dados, 1 Idioma

Grupos de itens: CRF Header, Form Administration, Target Lesion(s) Baseline Evaluation , Nontarget Lesion(s) Baseline Evaluation, Comments

Phase II Consortium - PHASE II LUNG CANCER - BASELINE SOLID TUMOR EVALUATION FORM Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FFA78C21-8B29-096C-E034-0003BA3F9857

SOUTHWEST ONCOLOGY GROUP LUNG CARCINOMA FIRST SITE(S) OF PROGRESSION OR RELAPSE FORM NCT00045162

- 09/06/2015 - 1 Formulário, 2 Grupos de itens, 11 Elementos de dados, 1 Idioma

Grupos de itens: Header, Comments

SOUTHWEST ONCOLOGY GROUP LUNG CARCINOMA FIRST SITE(S) OF PROGRESSION OR RELAPSE FORM NCT00045162 S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=001AFD84-A62B-538E-E044-0003BA3F9857

Lung Cancer NCT01336894 Response - ACOSOG-Z4099 Pretreatment RECIST Measurement Form (Arm 2) - 3178401v1.0 - ACOSOG-Z4099 Pretreatment RECIST Measurement Form (Arm 2)

- 09/01/2015 - 1 Formulário, 3 Grupos de itens, 11 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Visit, Pretreatment Measurement

ACOSOG-Z4099 Pretreatment RECIST Measurement Form (Arm 2) Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=986988FF-3289-FDB7-E040-BB89AD4317E3

Lung Cancer NCT01336894 Response - ACOSOG-Z4099 Active Monitoring RECIST Measurement Form (Arm 2) - 3178204v1.0 - ACOSOG-Z4099 Active Monitoring RECIST Measurement Form (Arm 2)

- 09/01/2015 - 1 Formulário, 4 Grupos de itens, 13 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Visit, Overall Response Status, Active Monitoring Measurement

ACOSOG-Z4099 Active Monitoring RECIST Measurement Form (Arm 2) Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9815654D-3AFA-EB3D-E040-BB89AD437C70

Southwest Oncology Group Follow-Up Tumor Assessment Form

- 03/07/2015 - 1 Formulário, 7 Grupos de itens, 26 Elementos de dados, 1 Idioma

Grupos de itens: SWOG clinical trial administrative data, Target Lesions, Non-target Disease, New Lesions, Symptomatic deterioration, Comments, CCRR MODULE

Southwest Oncology Group Follow-Up Tumor Assessment Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A50B6C19-55BD-164C-E034-080020C9C0E0

CALGB 30506 Treatment And Response Form NCT00863512

- 12/06/2015 - 1 Formulário, 7 Grupos de itens, 25 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Patient demographics, Patient Data, First Treatment (cycles 1 ¿ 6), Dose Modifications, Reason Treatment Ended, Footer Module

CALGB 30506 Treatment And Response Form NCT00863512 Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5E92C67F-DAF6-CFB0-E040-BB89AD432DA1

SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM NCT00045162

- 09/06/2015 - 1 Formulário, 6 Grupos de itens, 24 Elementos de dados, 1 Idioma

Grupos de itens: Header, TARGET LESIONS, NON-TARGET DISEASE, NEW LESIONS (specify site), Symptomatic deterioration, Comments

SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM NCT00045162 S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=001B724F-E7F0-4714-E044-0003BA3F9857

Palavras-chave

Índice

Modelos de dados selecionados